Skip to content
Screener

Omnicell OMCL Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
36M+12.5%
ICU Medical logo
ICU MedicalICUI
$179.64K+417,660%
Solventum logo
SolventumSOLV
$4.78M
Baxter International logo
Baxter InternationalBAX
LifeMD, Inc. logo
LifeMD, Inc.LFMD
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$68.3M+59.8%
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.7B+20.2%
Enterprise value$1.41B+37.3%
P/E36.4×
P/S1.4×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemJune 30,2026December 31,2025
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued
Common stock, $0.001 par value, 100,000 shares authorized; 58,419 and 57,833 shares issued; 45,613 and 45,027 shares outstanding, respectively5858
Treasury stock at cost, 12,806 shares outstanding(368,307)(368,307)
Additional paid-in capital1,250,3821,223,977
Retained earnings420,587384,940
Accumulated other comprehensive loss(11,115)(8,854)
Total stockholders’ equity1,291,6051,231,814

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's treasury stock, shares (in shares)?
Omnicell (OMCL) reported treasury stock, shares (in shares) of $12.81M in Q2 2026.
How has Omnicell's treasury stock, shares (in shares) changed year-over-year?
Omnicell's treasury stock, shares (in shares) increased by 18.4% year-over-year, from $10.82M to $12.81M.
What is the long-term trend for Omnicell's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Omnicell's treasury stock, shares (in shares) has grown at a 6.7% compound annual growth rate (CAGR), from $9.89M to $12.81M.
What does treasury stock, shares (in shares) mean?
Treasury stock, shares (in shares)

Ask your AI about Omnicell's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude